Dose-Optimization Trial of VXA-G1.1-NN in Healthy Volunteers

计划入组 66 人 · 首次发布于 2017 年 4 月 24 日

Immunogenicity and Safety of GBS-NN/NN2 in Pregnant Women

计划入组 269 人 · 首次发布于 2021 年 12 月 13 日

A Follow up Study of Group B Streptococcus (GBS)-NN/NN2 Vaccine in Healthy Volunteers

计划入组 29 人 · 首次发布于 2024 年 2 月 28 日

SNP-840

KP-840

MB-840

AliveGen USA, Inc.

United States

Wake Forest School of Medicine

United States

Johns Hopkins All Children's Hospital

United States

NanoNewron Secures $2.5M NIH Grant to Advance Blood-Brain Barrier Crossing TNF-Alpha Inhibitor for Alzheimer's Disease

Amgen Acquires Dark Blue Therapeutics for $840 Million to Advance AML Treatment

Amgen Acquires Dark Blue Therapeutics for Up to $840 Million to Advance Acute Leukemia Pipeline